Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

426 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Multimodal neuroimaging biomarkers and subtle cognitive decline in a population-based cohort without dementia.
Weinstein AM, Fang F, Chang CH, Cohen A, Lopresti BJ, Laymon CM, Nadkarni NK, Aizenstein HJ, Villemagne VL, Ilyas Kamboh M, Elizabeth Shaaban C, Gogniat MA, Wu M, Karikari TK, Ganguli M, Snitz BE. Weinstein AM, et al. Among authors: villemagne vl. J Alzheimers Dis. 2024 Dec 19:13872877241303926. doi: 10.1177/13872877241303926. Online ahead of print. J Alzheimers Dis. 2024. PMID: 39702989
[No title available]
[No authors listed] [No authors listed] PMID: 39750894
The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease.
Ellis KA, Bush AI, Darby D, De Fazio D, Foster J, Hudson P, Lautenschlager NT, Lenzo N, Martins RN, Maruff P, Masters C, Milner A, Pike K, Rowe C, Savage G, Szoeke C, Taddei K, Villemagne V, Woodward M, Ames D; AIBL Research Group. Ellis KA, et al. Int Psychogeriatr. 2009 Aug;21(4):672-87. doi: 10.1017/S1041610209009405. Epub 2009 May 27. Int Psychogeriatr. 2009. PMID: 19470201 Free article.
The Consortium for Clarity in ADRD Research Through Imaging (CLARiTI).
Mormino EC, Biber SA, Rahman-Filipiak A, Arfanakis K, Clark L, Dage JL, Detre JA, Dickerson BC, Donohue MC, Kecskemeti S, Hohman TJ, Jagust WJ, Keene DC, Kukull W, Levendovszky SR, Rosen H, Thompson PM, Villemagne VL, Wolk DA, Okonkwo OC, Rabinvovici GD, Rivera-Mindt M, Foroud T, Johnson SC. Mormino EC, et al. Among authors: villemagne vl. Alzheimers Dement. 2024 Nov 26. doi: 10.1002/alz.14383. Online ahead of print. Alzheimers Dement. 2024. PMID: 39588767 Review.
Detection and staging of Alzheimer's disease by plasma pTau217 on a high throughput immunoassay platform.
Feizpour A, Doecke JD, Doré V, Krishnadas N, Huang K, Bourgeat P, Laws SM, Fowler C, Robertson J, Mackintosh L, Ayton S, Martins R, Rainey-Smith SR, Taddei K, Ward L, Stage E, Bannon AW, Masters CL, Fripp J, Villemagne VL, Rowe CC. Feizpour A, et al. Among authors: villemagne vl. EBioMedicine. 2024 Nov;109:105405. doi: 10.1016/j.ebiom.2024.105405. Epub 2024 Oct 21. EBioMedicine. 2024. PMID: 39437657 Free PMC article.
Multi-analyte proteomic analysis identifies blood-based neuroinflammation, cerebrovascular and synaptic biomarkers in preclinical Alzheimer's disease.
Zeng X, Lafferty TK, Sehrawat A, Chen Y, Ferreira PCL, Bellaver B, Povala G, Kamboh MI, Klunk WE, Cohen AD, Lopez OL, Ikonomovic MD, Pascoal TA, Ganguli M, Villemagne VL, Snitz BE, Karikari TK. Zeng X, et al. Among authors: villemagne vl. Mol Neurodegener. 2024 Oct 10;19(1):68. doi: 10.1186/s13024-024-00753-5. Mol Neurodegener. 2024. PMID: 39385222 Free PMC article.
CYP1B1-RMDN2 Alzheimer's disease endophenotype locus identified for cerebral tau PET.
Nho K, Risacher SL, Apostolova LG, Bice PJ, Brosch JR, Deardorff R, Faber K, Farlow MR, Foroud T, Gao S, Rosewood T, Kim JP, Nudelman K, Yu M, Aisen P, Sperling R, Hooli B, Shcherbinin S, Svaldi D, Jack CR Jr, Jagust WJ, Landau S, Vasanthakumar A, Waring JF, Doré V, Laws SM, Masters CL, Porter T, Rowe CC, Villemagne VL, Dumitrescu L, Hohman TJ, Libby JB, Mormino E, Buckley RF, Johnson K, Yang HS, Petersen RC, Ramanan VK, Ertekin-Taner N, Vemuri P, Cohen AD, Fan KH, Kamboh MI, Lopez OL, Bennett DA, Ali M, Benzinger T, Cruchaga C, Hobbs D, De Jager PL, Fujita M, Jadhav V, Lamb BT, Tsai AP, Castanho I, Mill J, Weiner MW; Alzheimer’s Disease Neuroimaging Initiative (ADNI); Department of Defense Alzheimer’s Disease Neuroimaging Initiative (DoD-ADNI); Anti-Amyloid Treatment in Asymptomatic Alzheimer’s Study (A4 Study) and Longitudinal Evaluation of Amyloid Risk and Neurodegeneration (LEARN); Australian Imaging, Biomarker & Lifestyle Study (AIBL); Saykin AJ. Nho K, et al. Among authors: villemagne vl. Nat Commun. 2024 Sep 20;15(1):8251. doi: 10.1038/s41467-024-52298-2. Nat Commun. 2024. PMID: 39304655 Free PMC article.
Implementation and Assessment of Tau Thresholds in Non-Demented Individuals as Predictors of Cognitive Decline in Tau Imaging Studies.
Gogola A, Cohen AD, Snitz B, Minhas D, Tudorascu D, Ikonomovic MD, Shaaban CE, Doré V, Matan C, Bourgeat P, Mason NS, Leuzy A, Aizenstein H, Mathis CA, Lopez OL, Lopresti BJ, Villemagne VL; Alzheimer’s Disease Neuroimaging Initiative. Gogola A, et al. Among authors: villemagne vl. J Alzheimers Dis. 2024;100(s1):S75-S92. doi: 10.3233/JAD-240543. J Alzheimers Dis. 2024. PMID: 39121123
The ADNI PET Core at 20.
Jagust WJ, Koeppe RA, Rabinovici GD, Villemagne VL, Harrison TM, Landau SM; Alzheimer's Disease Neuroimaging Initiative. Jagust WJ, et al. Among authors: villemagne vl. Alzheimers Dement. 2024 Oct;20(10):7340-7349. doi: 10.1002/alz.14165. Epub 2024 Aug 6. Alzheimers Dement. 2024. PMID: 39108002 Free PMC article. Review.
426 results